N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide

C97H100N34O5S — CID 159593784

IUPACN,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide
SMILESCc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)N(C)Cc3nccs3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)N3CCN(CCN4CCOCC4)CC3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)NCc3ccccn3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)NCc3ccn[nH]3)[nH]c12
InChIInChI=1S/C28H35N9O2.C24H22N8O.C23H22N8OS.C22H21N9O/c1-20-15-22(31-28-29-4-3-23(33-28)25-18-34(2)19-30-25)16-21-17-24(32-26(20)21)27(38)37-9-7-35(8-10-37)5-6-36-11-13-39-14-12-36;1-15-9-18(29-24-26-8-6-19(31-24)21-13-32(2)14-28-21)10-16-11-20(30-22(15)16)23(33)27-12-17-5-3-4-7-25-17;1-14-8-16(27-23-25-5-4-17(29-23)19-11-30(2)13-26-19)9-15-10-18(28-21(14)15)22(32)31(3)12-20-24-6-7-33-20;1-13-7-16(27-22-23-5-4-17(29-22)19-11-31(2)12-25-19)8-14-9-18(28-20(13)14)21(32)24-10-15-3-6-26-30-15/h3-4,15-19,32H,5-14H2,1-2H3,(H,29,31,33);3-11,13-14,30H,12H2,1-2H3,(H,27,33)(H,26,29,31);4-11,13,28H,12H2,1-3H3,(H,25,27,29);3-9,11-12,28H,10H2,1-2H3,(H,24,32)(H,26,30)(H,23,27,29)
InChIKeyMKOKIDBCVXMMQX-UHFFFAOYSA-N
MW1854.17 g/mol
LogP13.44
Rot. Bonds25

About N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide

N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide (PubChem CID 159593784) has the molecular formula C97H100N34O5S and a molecular weight of 1854.17 g/mol. Its IUPAC name is N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide.

Molecular Properties

Compound NameN,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide
PubChem CID159593784
Molecular FormulaC97H100N34O5S
Molecular Weight1854.17 g/mol
Exact Mass1852.83
IUPAC NameN,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide
SMILESCc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)N(C)Cc3nccs3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)N3CCN(CCN4CCOCC4)CC3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)NCc3ccccn3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)NCc3ccn[nH]3)[nH]c12
InChIInChI=1S/C28H35N9O2.C24H22N8O.C23H22N8OS.C22H21N9O/c1-20-15-22(31-28-29-4-3-23(33-28)25-18-34(2)19-30-25)16-21-17-24(32-26(20)21)27(38)37-9-7-35(8-10-37)5-6-36-11-13-39-14-12-36;1-15-9-18(29-24-26-8-6-19(31-24)21-13-32(2)14-28-21)10-16-11-20(30-22(15)16)23(33)27-12-17-5-3-4-7-25-17;1-14-8-16(27-23-25-5-4-17(29-23)19-11-30(2)13-26-19)9-15-10-18(28-21(14)15)22(32)31(3)12-20-24-6-7-33-20;1-13-7-16(27-22-23-5-4-17(29-22)19-11-31(2)12-25-19)8-14-9-18(28-20(13)14)21(32)24-10-15-3-6-26-30-15/h3-4,15-19,32H,5-14H2,1-2H3,(H,29,31,33);3-11,13-14,30H,12H2,1-2H3,(H,27,33)(H,26,29,31);4-11,13,28H,12H2,1-3H3,(H,25,27,29);3-9,11-12,28H,10H2,1-2H3,(H,24,32)(H,26,30)(H,23,27,29)
InChIKeyMKOKIDBCVXMMQX-UHFFFAOYSA-N
XLogP13.44
TPSA454.67 Ų
H-Bond Donors11
H-Bond Acceptors31
Rotatable Bonds25
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001854.17
LogP ≤ 513.44
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1031

Analyze N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide?
The IUPAC name of N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide (CID 159593784) is N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide.
What is the SMILES notation for N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide?
The canonical SMILES for N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide is Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)N(C)Cc3nccs3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)N3CCN(CCN4CCOCC4)CC3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)NCc3ccccn3)[nH]c12.Cc1cc(Nc2nccc(-c3cn(C)cn3)n2)cc2cc(C(=O)NCc3ccn[nH]3)[nH]c12.
What is the InChIKey of N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide?
The InChIKey is MKOKIDBCVXMMQX-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H35N9O2.C24H22N8O.C23H22N8OS.C22H21N9O/c1-20-15-22(31-28-29-4-3-23(33-28)25-18-34(2)19-30-25)16-21-17-24(32-26(20)21)27(38)37-9-7-35(8-10-37)5-6-36-11-13-39-14-12-36;1-15-9-18(29-24-26-8-6-19(31-24)21-13-32(2)14-28-21)10-16-11-20(30-22(15)16)23(33)27-12-17-5-3-4-7-25-17;1-14-8-16(27-23-25-5-4-17(29-23)19-11-30(2)13-26-19)9-15-10-18(28-21(14)15)22(32)31(3)12-20-24-6-7-33-20;1-13-7-16(27-22-23-5-4-17(29-22)19-11-31(2)12-25-19)8-14-9-18(28-20(13)14)21(32)24-10-15-3-6-26-30-15/h3-4,15-19,32H,5-14H2,1-2H3,(H,29,31,33);3-11,13-14,30H,12H2,1-2H3,(H,27,33)(H,26,29,31);4-11,13,28H,12H2,1-3H3,(H,25,27,29);3-9,11-12,28H,10H2,1-2H3,(H,24,32)(H,26,30)(H,23,27,29).
What are the key properties of N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide?
N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide has a molecular weight of 1854.17 g/mol, XLogP of 13.44, 25 rotatable bonds, 11 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for N,7-dimethyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1,3-thiazol-2-ylmethyl)-1H-indole-2-carboxamide;[7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-1H-indol-2-yl]-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]methanone;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(1H-pyrazol-5-ylmethyl)-1H-indole-2-carboxamide;7-methyl-5-[[4-(1-methylimidazol-4-yl)pyrimidin-2-yl]amino]-N-(pyridin-2-ylmethyl)-1H-indole-2-carboxamide is sourced from PubChem (CID 159593784), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).